FOXP3 may behave as a transcriptional repressor of SKP2 and HER2, acting as a potential tumor-suppressor gene in breast cancer [47,48], prostate [49], gastric cancer [50], or hepatocellular carcinoma [51]. This evidence concerns the gene ERBB2 and breast carcinoma.